ArticleCureus2020

Initial Experience after Transition to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer Treated in a Rural Healthcare Region.

Carsten Nieder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.